Open Access

Pituitary apoplexy after surgery for cervical stump adenocarcinoma: A case report and literature review

  • Authors:
    • Xiaodan Yu
    • Chen Shi
    • Lili Jiang
    • Kuiran Liu
  • View Affiliations

  • Published online on: June 28, 2024     https://doi.org/10.3892/ol.2024.14543
  • Article Number: 411
  • Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Pituitary apoplexy (PA) is an emergency condition caused by sudden hemorrhage or infarction and characterized by sudden sella turcica compression, intracranial hypertension and meningeal stimulation. PA usually occurs secondary to pituitary adenomas and can serve as the initial manifestation of an undiagnosed pituitary adenoma in an individual. In the present study, a case of PA following surgery for cervical stump adenocarcinoma was reported. The patient experienced an abrupt onset of headache and drowsiness on postoperative day 1 (POD1), and developed blurred vision and blepharoptosis of the left eye on POD4. Pituitary MRI confirmed the diagnosis of PA, prompting the initial administration of hydrocortisone to supplement endogenous hormones, followed by trans‑sphenoidal resection. At the six‑week follow‑up, the patient had fully recovered, with only mild residual blurring of vision. Diagnosing PA post‑surgery can be a challenging task due to its symptomatic overlap with postoperative complications. The existing literature on PA after surgery was also reviewed, including the symptoms, time of onset, imageological examination, management, potential risk factors and outcome to improve on early detection and individualized treatment in the future.

Introduction

The term pituitary apoplexy (PA) was initially introduced by Brougham in 1950 (1), defined as an emergency condition caused by hemorrhage or infarction of the pituitary gland. However, PA can be generally neglected in 25% of pituitary tumors and there may only be radiological or histopathological evidence of infarction and/or hemorrhage without any clinical manifestation (2). In the present article, PA refers to clinically diagnosed PA with classical symptoms.

The prevalence of PA reported in different studies ranges from 0.6 to 7% (37), suggesting that numerous cases were undiagnosed and did not receive any clinical attention (8). While the pathophysiology of PA remains elusive, several risk factors have been identified, such as fluctuation of blood pressure (BP), use of anticoagulant drugs, major surgeries, pregnancy and pituitary function test (911). Clinical symptoms vary from person to person, commonly manifesting as sudden onset of headache, visual field defect, diplopia, ophthalmoplegia, decreased consciousness, increased urine volume, nausea and vomiting (1214). Dysfunctions in the hypothalamic-pituitary hormone axis can result in a lack of various pituitary-related hormones, which may lead to physiological disorders in several ways (Fig. 1). Hypothyroidism and adrenal insufficiency secondary to PA may weaken the body's tolerance to surgical trauma. Glucocorticoid and thyroid hormones both have a role in post-operative stress. Glucocorticoids help maintain BP and blood sugar, facilitate fat mobilization, combat cellular damage and suppress inflammatory responses (15), and thyroid hormones can speed up the metabolism and increase peripheral cells' utilization of glucose (16). The choice of treatment between hormonal replacement therapy and trans-sphenoidal resection is determined based on the severity of neuro-ophthalmic symptoms and the patient's capacity to undergo a second surgery (2).

However, presenting as the initial sign of unknown pituitary tumors, it can be a challenging task to diagnose PA post-surgery due to its symptomatic overlap with postoperative complications. It is a rare postoperative complication that may have severe consequences if not treated timely and properly. Due to the lack of reviews on PA after surgery, the current article presented a clinical case and summed up the characteristics of relevant cases published over the years.

Case report

A 64-year-old female with a history of subtotal hysterectomy 20 years prior presented with vaginal bleeding persisting for three months and was admitted in Shengjing Hospital of China Medical University (Shenyang, China) in March 2023. The patient's body mass index was 24.2 kg/m2 (body height, 164 cm; body weight, 65 kg). The obstetric history included two pregnancies-one ending in abortion and the other in a vaginal birth. At the age of 44 years, the patient underwent a subtotal hysterectomy and left adnexectomy due to multiple uterine leiomyomas and a lateral ovarian cyst, with postoperative pathology confirming benignity. Irregular human papillomavirus (HPV) and thinprep cytology test (TCT) screening were conducted post-surgery, and the last screening was 2 years prior and the results remained negative. After undergoing minor but persistent vaginal bleeding for 3 months, the patient tested HPV-16 positive and negative for intraepithelial lesion or malignancy on TCT. The pelvic ultrasound, computerized tomography (CT) and positron emission tomography-computed tomography (PET-CT) identified a moderately hyperechoic mass in the cervical stump region, which was highly suggestive of cancer (Fig. 2). Gynecological examination revealed normal vulvar development with signs of aging and a smooth vaginal canal. An exogenous lesion with a diameter of ~2.5 cm was observed at the stump of the cervix, exhibiting lesion contact bleeding. The anterior fornix was shallow and the pelvic cavity was with no obvious abnormalities in the adnexal areas. The patient reported no comorbidities, aside from a sulfonamide allergy. General examination was unremarkable, except for admission BP of 148/96 mmHg. According to the latest guideline of hypertension in China (17), hypertension was defined as systolic BP ≥140 mmHg/or diastolic BP ≥90 mmHg. The patient's BP was monitored and a cardiologist was consulted. During hospitalization, the patient's BP was stable, ranging from 120/80 to 140/90 mmHg. The patient cooperated well in the physical examination. The bilateral pupils were equally large and round with a diameter of 3 mm and had no limitation of eye movement or visual field defect. The patient exhibited full mobility in all four limbs with normal muscle force and strength and neither had a history of pituitary adenoma nor manifested any related symptoms. The patient underwent tissue biopsy and cervical stump adenocarcinoma was diagnosed. After comprehensive pre-operative evaluations, including PET-CT, the patient underwent open extensive stump cervicectomy, pelvic lymph node dissection and transcystoscopic bilateral ureteral stenting. Pelvic drainage and vaginal drainage were used. The surgery proceeded smoothly with an intraoperative bleeding volume of 100 ml. Intraoperative anesthesia and medication details are provided in Fig. S1 [Illustrator 27.7 (Adobe, Inc.) was used to generate the translated version of this image]. The patient's BP remained stable during the operation and no hypotension was detected prior to or after the surgery. After the gynecological operation, the patient was treated with intravenous cefazolin sodium (Sinopharm CNBG Zhongnuo Pharmaceuticals Co., Ltd.) 0.5 g per 8 h, intramuscular enoxaparin sodium [Sanofi Aventis (Beijing) Pharmaceutical Co., Ltd.] 40 mg per day, intravenous methylprednisolone (Pharmacia & Upjohn Co., Ltd.) 20 mg per day and other supportive care (methylprednisolone is administered as a common treatment at the Enhanced Recovery After Surgery ward to alleviate peri-operative stress and inflammation). From postoperative day 1 (POD1), the patient complained of the sudden onset of a headache [pain visual analogue scale (VAS) score (18), 4/10] and drowsiness. Since the pre-operative PET-CT did not indicate any pituitary tumor (Fig. 3A), it was inferred that the patient's symptoms may be due to general anesthesia and the postoperative analgesia pump and the pump was turned off immediately. On POD2, the patient still reported headaches and a neurosurgery consultation was started. The neurosurgery doctor suggested recording a head CT but the patient perceived her headache to be of mild severity and signed to refuse relevant tests. On POD3, the patient's BP fluctuated between 120/70 and 145/85 mmHg. It was not until the patient's headache worsened (pain VAS 7/10) and a new complaint of blurred vision and blepharoptosis of the left eye occurred on POD4 that she consented to further examination. The patient's Glasgow coma scale score was 3-5-6 points (19). A head CT scan and an ophthalmic consultation were carried out immediately, revealing multiple lacunar infarctions and local density increases in the sella turcica and suprasellar regions (Fig. 3B). Enhanced pituitary MRI showed a 2.4×1.7×2.6 cm occupation in the sellar area with a heterogeneous signal, indicating a pituitary macroadenoma with apoplexy (Fig. 3C and D). Ophthalmic assessments showed bitemporal hemianopsia and abnormal findings in the fundus photography and visual pathway images (data not shown). Laboratory tests indicated panhypopituitarism (Table I). The patient was promptly transferred to the neurosurgery ward. Considering the visual field defect was stable, there was no indication of an emergency surgery and hydrocortisone (Tianjin Jinyao Amino Acid Co., Ltd.; 100 mg/day) replacement therapy was used to complete enhanced head CT and arterial angiography, and transsphenoidal hypophysical lesion resection through the neuroendoscope under general anesthesia was carried out successfully on POD12. After the neurosurgery operation, the patient took desmopressin acetate tablets [Huilin (Sweden) Pharmaceuticals Co., Ltd.] 0.1 mg to treat postoperative diabetes insipidus, sustained-release potassium tablets (Shenzhen Zhonglian Pharmaceutical Co., Ltd.) 1 g three times per day to treat hypokalemia and prednisolone acetate tablets (Tianjin Tianyao Pharmaceuticals Co., Ltd.) 10 mg at 8:00 a.m. and 5 mg at 4:00 p.m. each day. Postoperative pathology was performed by reticulin fiber staining with kit no. G3535 from Solarbio Science and Technology (Beijing) Co., Ltd (20), and it indicated hemorrhage of pituitary tumor (Fig. 4). The patient reported complete resolution of headaches, bitemporal hemianopia and visual field improvement the day after the operation and was discharged from the hospital a week later. The patient reported mild blurry vision during the follow-up of six weeks after the neurosurgery operation. After discharge, the patient underwent follow-up every three months, and her hormone levels completely returned to normal. The patient was advised to undergo hormone level assessments and pituitary imaging every six months, with continued lifelong follow-up.

Table I.

Hormone and ion levels of the patient at different stages.

Table I.

Hormone and ion levels of the patient at different stages.

Time-pointK+, mmol/lNa+, mmol/lFT3, pmol/lFT4, pmol/lTSH, µmol/lACTH-8:00 a.m., pg/mlCortisol-8:00 a.m., µg/dlFSH, µIU/mlLH, µIU/mlProlactin, ng/ml
Pre-operation3.7813949.421.7516.7415.623.456.0938.28
Between two operations3.27↓135↓2.486.81↓0.19↓3.83↓5.63↓3.77↓<0.2↓1.13↓
Post-operation3.24↓137<1.54↓8.48↓0.2↓2.25↓11.942.49↓<0.2↓1.57↓
6 weeks after the operation4.491413.2412.220.911.910.112.41↓0.62↓3.75
Normal ranges3.5–5.5136-1452.43–6.019.01–19.050.3–4.87.2–66.36.02–18.46.74–113.5910.87–58.642.74–19.64

[i] K+, potassium ion; Na+, sodium; FT3, free triiodothyronine; FT4, free thyroxine; TSH, thyroid stimulating hormone; ACTH, adrenocorticotropic hormone; FSH, follicle-stimulating hormone; LH, luteinizing hormone; ↓, decreased.

Discussion

PA is a rare postoperative complication that may be life-threatening if not diagnosed and treated properly. It is usually caused by a sudden ischemic or hemorrhagic infarction of a preexisting pituitary adenoma, while only pituitary apoplexy rarely occurs in normal pituitary glands. Bonicki et al (3) reported that PA occurs in 5% of patients with pituitary adenomas; however, >40% of PA cases have never been diagnosed with a pituitary tumor prior to onset (21). PA is related to a variety of inducible factors, but its exact pathogenesis remains elusive. Due to the specific features of the pituitary vascular system, pituitary tissue is more susceptible to hypoperfusion, ischemia and intraoperative embolism, particularly during pump-on surgery. During the literature review for the current study, it was found that predisposing factors of PA included not only transient hypertension or hypotension, but also diabetes, angiographic test, cardiac surgery, hemodialysis, pituitary dynamic function test, radiation therapy, positive pressure mechanical ventilation and anticoagulant therapy (22).

To the best of our knowledge, the present study was the first case report of PA after gynecological malignancy. Since the pre-operative PET-CT did not indicate any pituitary tumor, postoperative symptoms such as headache, visual field defect, ptosis and hypopituitarism were confused with common postoperative complications and PA was not detected in the initial stage. This may be for the following two primary reasons. First, PET-CT lacks specificity and sensitivity in the hypothalamic-pituitary region, potentially resulting in undetected pituitary microadenomas. Furthermore, the pituitary adenoma became enlarged due to hemorrhage post-surgery, thereby facilitating detection. However, headaches likely occurred due to extravasation of blood into the subarachnoid space, causing meningeal irritation (22). Bitemporal hemianopia is the most common type of visual field defect caused by a pituitary tumor, which occurs due to the PA pressing on the middle of the optic chiasma (14). Ptosis presented as a result of oculomotor nerve compression and hypopituitarism was a sign of pituitary dysfunction. Besides, severe hypoglycemia and hyponatremia may occur due to a reduced glucocorticoid effect because of low cortisol response, as well as water overload caused by adrenocorticotropic hormone deficiency.

A total of four primary factors contributing to the occurrence of PA were identified for the present case. First, general anesthesia carries a greater risk of low BP than local anesthesia. General anesthesia may also lead to reduced cerebral perfusion. Second, surgery can cause intravascular fluid to spread into the interstitial space, leading to edema and a drop in BP. Third, blood loss may also be a contributing factor. Although only 100 ml of blood loss was stated in the surgical record, the patient underwent a major resection and lymph node dissection with postoperative nausea and vomiting, which indicated the possibility of local bleeding after abdominal closure and blood loss may be difficult to estimate accurately. Fourth, anticoagulant therapy is another risk factor, as it increases the risk of bleeding from damaged pituitary tissue.

PA can also occur in various types of surgery, particularly in surgery of the circulatory system. A literature search was conducted through PubMed, using ‘pituitary apoplexy’ and ‘surgery or operation’ as key terms to identify relevant articles published between 1984 and 2023. The search was limited to articles in English and only studies with sufficient information were included in the literature review (Table II). Based on the literature review, PA after surgery mostly occurred in males (76%), with an average age of 53 years for women and 68 years for men. Only 8% of cases had known pituitary disease (23,24). Clinical symptoms usually occur on the operation day or on POD1 (72%) and headache (76%) was the main and the earliest complaint in most cases. This symptom was possibly triggered by dural stretching and meningeal irritation caused by extravasation of blood and necrotic tissue into the subarachnoid space (25). Further examination of the literature indicated that visual disturbances were mentioned in 64% (visual deterioration in 24%, diplopia in 24%, visual defects in 20% and loss of light reflex in 20%), which was caused by pressure on different parts of the optic nerve and oculomotor nerve involvement may present as ptosis (44%). In addition, adrenal insufficiency may reduce the level and the efficiency of glucocorticoids and eventually cause arterial hypotension and/or hypoglycemia, as well as varying degrees of consciousness change, which was noted in 12% of cases in the present review.

Table II.

Summary of information on PA cases during and after surgery from the literature review and the present case.

Table II.

Summary of information on PA cases during and after surgery from the literature review and the present case.

Authors, yearAge, years/sexPrior lesionOperation methodClinical presentationOnset timePituitary imaging MRI/CTPotential risk factorsTreatment hormone replacement therapySurgeryPrognosis(Refs.)
Mura et al,85/maleLaparoscopicLeft palpebralDuring theCT: Pituitary glandPreoperativeDexamethasone(34)
2014 colorectalptosis,operationincrease;anticoagulant4 mg ×2/day
resectionanisocoria, MRI: Pituitary glandtherapy,
divergent increase withintraoperative
strabismus, hematomaBP fluctuation
mydriasis
without photo-
motor reflex
McClain et al,75/femaleElectiveHeadache,POD1CT: A large sellarHistory ofUrgentPtosis and(35)
2022 rotatorvomiting, mass;essential transsphenoidalophthal-
cuff repairdiplopia, MRI: A sellar andhypertension endoscopicmoplegia
inability to suprasellar mass resection of thecompletely
open the effect compressing pituitary massrecovered
right eye the optic chiasm and visual
field deficits
stabilized
Liberale et al,73/maleSubrenalDiplopia, rightOn theMRI: A large sellarPreoperativeCortisone TranssphenoidalPartially(36)
2006 aorticpalpebraloperationmass compressinganticoagulantacetate 50 mg/adenectomyrecovered the
abdominalptosis,dayback carotid arteriestherapymorning and right third
aneurysmmydriasis, and the optical 25 mg/evening, oculomotor
repair bydivergent chiasma sodique palsy and
subcostalstrabism levothyroxin, remained
bilateral 50 g/day stable during
laparotomy the 4-year
follow-up
Naito et al,14/femaleRecurrentHeadachePOD1CT: A tumorHemodynamicl-T4 treatmentImproved(37)
2019 cardiacand visual surrounding theinstabilityfor 3 months visual field
myxomaimpairment hypothalamopituitaryduring surgery, of both eyes
resection lesion;use of before
surgery MRI: An intra- andanticoagulant discharge
supra-sellar tumor
compressing optic
chiasma and bilateral
optic nerves
Hidiroglu et al,47/maleCoronaryPtosis of bothPOD2CT: A solid mass Transsphenoidal(38)
2010 artery bypasseyes, headache compressing the optic adenectomy
grafting chiasm
operation
Yakupoglu et al,74/maleOpen three-Right ophtha-6 h afterCT: A mass on theHemodynamicIntravenousTranscranialFull recovery(39)
  2010 vessellmoplegia withthepituitary gland;changeshydrocortisoneadenomaof ptosis,
CABG andptosis, rightoperationMRI: Pituitary 50 mg/day, oralexcisionvisual field
insertion ofmydriasis, macroadenoma with levothyroxine deficits and
a saphenousheadache haemorrhage and 0.2 mg/day mental
vein graft infarction changes
within
2 weeks of
surgery
Yoshino et al,78/maleRight upperHeadache,POD6MRI: A high-HydrocortisoneComplete(40)
2014 and middlesudden intensity area inside 200 mg/day recovery
lobectomyincrease in the pituitary gland
and lymphurine volume
node
dissection
Joo et al, 201873/maleLumbarSeverePOD2CT and MRI:IntraoperativeHydrocortisone TranssphenoidalImproved(41)
fusionheadache, A mass in the sellarBP fluctuation300 mg/dayhypophysectomyptosis and
surgeryophthalmalgia fossa and suprasellar anisocoria
in proneand ptosis region, compressing
positionon right eye the optic chiasm
Goel et al, 200976/maleElective leftSuddenPOD1CT: A mass in theTransientDexamethasoneTransnasalComplete(42)
total hipheadache, left pituitary fossa;episode of2 mg/6 htransphenoidalrecovery
athroplastytotal left vision MRI: Intersellar masshypotension in decompression
loss and with a suprasellarthe postoperative of the pituitary
temporal right extension on theperiod tumor
hemianopia left side, compressing
the optic chiasma
and cavernous sinus
Goel et al, 200961/maleElective leftSuddenPOD1CT: An intersellarMicroembolismHigh-doseCraniotomy andComplete(42)
total kneeheadache, tumor dexamethasonedecompressionrecovery
athroplastynausea, intravenouslyof pituitary
vomiting, adenoma
right ptosis
Kim et al, 201569/maleOpen heartSevereAfter theMRI: A sellar massExcessiveHigh-dose TranssphenoidalComplete(43)
mitralheadache,operationwith hemorrhage anticoagulation,steroidsresection of therecovery
valvuloplastyvisual field pituitaryhemodynamic tumor
defects, macroadenomainstability
double vision
Mizuno et al,73/maleElectiveRight ptosis4 h afterCT and MRI:StrongEndonasalComplete(44)
2011 coronarywith completelythe surgeryA large heparinization, transsphenoidalrecovery
artery bypassdilated pupils, suprasellar massBP fluctuation resection of the
graftinglight reflex with bleedingduring CPB pituitary gland
loss, headache
Thurtell et al,79/maleCoronaryBlindness,FollowingCT: A large pituitaryHemodilution,Intravenous TranssphenoidalRemained(45)
2008 artery bypassno lightextubationmass;hypotension,dexamethasonedecompressionblind with
graftingperception, MRI: The mass anticoagulationsodium no light
miosis extended into the phosphate 8 mg perception
suprasellar cistern on follow-up
and compressed the
optic chiasm
Thurtell et al,64/maleCoronaryBlindness,FollowingCT: A large pituitaryHemodilution,Intravenous TranssphenoidalRemained(45)
2008 artery bypassno lightextubationmass;hypotension,dexamethasonedecompressionblind with
graftingperception, MRI: The mass anticoagulationsodium no light
miosis extended into the phosphate perception
suprasellar cistern 12 mg on follow-up
and compressed
the optic chiasm
Matsusaki et al,56/femaleLiving donorHeadache,POD10CT: A high-densityIntraoperativePrednisolone,Complete(46)
2011 liver trans-thirst, frequent area in the pituitaryhypotension,20 mg/days recovery
plantationurination gland;coagulopathy,
MRI: A suspicioustransient
area between thehypertension,
anterior and posteriordopamine
of the pituitary glandagonist therapy
Telesca et al,70/maleElectiveHeadache,FollowingCT and MRI: A sellarHigh-doseComplete(47)
2009 coronaryvisual fieldextubationmass with suprasellar steroids recovery
bypassdefects, extension
surgerydiplopia
Fyrmpas et al,67/maleNon-BilateralReducedPOD2CT and MRI:Hypertension,CorticosteroidMicroscopicRegained(23)
2010 secretingendoscopicvision, Haemorrhage withindiabetes,replacementendoscopicvision and
pituitarymiddlediplopia, the pituitary tumor anticoagulationtherapy transsphenoidaloculomotor
macro-meatalheadache therapy, resectionnerve
adenomaantrostomy, prolonged function
ethmoidec- intraoperative partly
tomy and hypotension
polypectomy
Absalom et al,61/maleNon-CoronarySudden onset40 h afterCT: A 3-cmPreoperativeMannitol 80 gCraniotomy, de-Dead of(24)
1993 secretingartery bypassof headache,the surgerysuprasellar massanticoagulantandcompression ofacute
pituitarygraftingnausea, with a largetherapy, suddendexamethasonethe optic nerves,myocardial
tumor vomiting bleeding area incoronary10 mg ivintracapsularinfarction
the pituitary revascularization removal of
pituitary tumor
Madhusudhan62/maleRight totalBilateralPOD5CT: A lowPreoperativeHydrocortisoneComplete(48)
et al, 2011 shoulderfrontal attenuation signalanticoagulantand thyroxine recovery
replacementheadaches, in the pituitarytherapy,supplements,
binocular fossa;postoperativetestosterone
diplopia, MRI: The pituitaryhypoperfusionreplacement
increased stalk was markedly therapy
urinary output, deviated to the right
confusion, with an enhancing
drowsiness area in the pituitary
fossa, suggesting an
adenoma
Cohen et al,50/femaleLiposuctionPersistentAfter theMRI: An intrasellarLarge dose of TranssphenoidalComplete(49)
2004 on abdomen,headache,surgeryand suprasellar masslocal anesthetic, resection of therecovery
hips andnausea, extending into thehypovolemia, pituitary mass
thighsvomiting right cavernous sinusfluid overload
Shapiro, 199060/femaleCoronaryHeadache,POD1CT: A right-sidedReducedHydrocortisone TranssphenoidalThird nerve(50)
artery bypasssevere right sellar mass withperfusion50 mg everysurgerypalsy
surgeryptosis, extension into thepressure during6 h persisted
unresponsive sphenoid sinus; cardiopulmonary post-
pupil on the MRI: A pituitarybypass, operatively
right side tumor with surroun-anticoagulant
ding hemorrhagetherapy
Tansel et al,60/maleCoronaryUnexplainedFollowingMRI: PituitaryProtamine Hydrocortisone,In good(51)
2010 artery bypassepisodes ofextubationinfarction hypersensitivitytestosterone, condition
graftinghypotension, thyroxin except for
dysrhythmia, a certain
electrolyte degree of
imbalances, visual
somnolence, disturbance
agitation,
respiratory
distress, high
fever
Slavin and57/maleThree-vesselMild periorbitalAwakeningCT: An intrasellarIntraoperative Corticosteroids TranssphenoidalComplete(52)
Budabin, 1984 coronarypain, unablefrommass with rightor postoperative hypophysectomyrecovery
bypassto open rightanesthesiaparasellar extensionhypotension, except for a
surgeryeye, headache anticoagulation, mild visual
positive pressure field defect
ventilation
Slavin and55/maleMitral valveBilateralAfter theCT: An intrasellarIntraoperative Corticosteroids TranssphenoidalComplete(52)
Budabin, 1984 replacementblepharoptosissurgerymass with largeor postoperative hypophysectomyrecovery
under cardio-and partial oph- radiolucent areashypotension, except for
pulmonarythalmoplegia encroaching on the anticoagulation, a mild right
bypasson each side, right cavernous sinuspositive pressure abduction
bilateral ventilation defect
confrontation
visual fields
disclosed nasal
field defects
Present case,64/femaleExtensiveSudden onsetPOD1CT: MultipleReduced cerebralHormoneMicroscopicComplete
2024 stumpof headache, lacunar infarctionsperfusion,replacementendoscopicrecovery
cervicectomy,drowsiness and local densityanticoagulanttherapy transsphenoidalexcept for a
pelvic lymph increase in saddletherapy resectionmild blurry
node and suprasellar vision
dissection region;
MRI: The pituitary
was enlarged and
mixed signals were
seen

[i] POD, post-operative day; BP, blood pressure; CPB, cardiopulmonary bypass.

The diagnosis of PA is based on imaging evaluation, mainly by MRI, which is more sensitive than CT. Pituitary MRI is the radiological examination of choice (26). It can identify areas of bleeding and necrosis and determine the relationship between the tumor and neighboring structures, such as the optic chiasm, cavernous sinuses and hypothalamus (27). However, CT is also an examination that cannot be ignored, which can exclude headaches caused by subarachnoid hemorrhage and make a tentative diagnosis of intrasellar mass in most cases (28). In the present review, 80% of cases were detected by CT and 80% by MRI.

Endocrine deficiencies can exist at the onset and urgent evaluation of hormonal levels is suggested. According to the latest guidelines from Oxford and Royal College of Physicians (29), empirical hormonal replacement is indicated in each patient with secondary adrenal insufficiency no matter whether to perform a surgery or not. Applying hydrocortisone 100–200 mg intravenously and then applying either continuous intravenous infusion 2–4 mg/h or intramuscular injection 50–100 mg/6 h are suggested. Reviewing the series of patients with PA, 84% of cases received hormonal replacement therapy regardless of whether surgery was performed, while 72% of cases ended up receiving neurosurgical intervention. Applying exogenous hormones alone has certain inherent imperfections, as different hormones can influence the regulation of each other to a certain extent (30). The indications for surgery following hormonal replacement are as follows: i) Evidence of worsening or persistent neurological symptoms, such as visual impairment and ophthalmoplegia (paralysis or weakness of the eye muscles); ii) altered mental state; iii) patient is stable (no progressive deterioration in visual or mental state) and shows improvement with conservative treatment (26). Most cases (84%) achieved partial or complete remission in the visual field and ophthalmoplegia after prompt treatment. However, most studies demonstrate that surgical treatment, usually within 7 days of the event, leads to a higher rate of recovery from visual impairment (31). Nevertheless, certain retrospective studies confirm that there is no significant difference in the recovery of vision and endocrine function between patients with pituitary tumors treated conservatively and those undergoing surgical decompression (32,33). Currently, there is a lack of high-level evidence-based medical evidence for choosing a treatment approach. The UK guidelines for the management of pituitary tumor apoplexy recommend that the treatment plan should be determined through multidisciplinary collaboration, considering emergency surgical treatment based on the patient's pituitary apoplexy score evaluation (9).

A limitation of this study was the omission of ophthalmic assessment figures. These results were not included in our hospital's electronic medical records. Consequently, only copies of photographs of these results are available. Additionally, paper reports were not preserved, precluding the possibility of scanning them for enhanced clarity.

In conclusion, this review emphasized that even as an uncommon postoperative complication, PA is potentially life-threatening. It may occur in postoperative patients either with diagnosed or undiagnosed prior pituitary adenoma. Early diagnosis is essential for the timely treatment of hypopituitarism and prevention of serious neurological complications. In short, the wise surgeon should: i) Recognize PA after surgery in a timely manner by obtaining early neuroimaging tests and pituitary-related hormone tests and remember MRI is more sensitive than CT in observing early changes of hemorrhage or infarction. ii) Take initial action, such as applying intravenous glucocorticoids and mannitol. Transsphenoidal surgery should be considered and performed at the early stage of PA, if possible, to achieve better recovery. iii) If vision and the visual field are not affected, or vision defects are stable or temporary, hormonal replacement therapy alone may be considered, which is more appropriate for patients with surgical contraindications and may also spare patients from unnecessary surgery.

Supplementary Material

Supporting Data

Acknowledgements

Not applicable.

Funding

Funding: No funding was received.

Availability of data and materials

The data generated in the present study may be requested from the corresponding author.

Authors' contributions

KL and XY conceived the study and revised the manuscript. CS made substantial contributions to the acquisition and analysis of the data and drafted the tables of the manuscript. LJ drafted the figures of the manuscript and interpreted the data. All authors read and approved the final manuscript. XY and KL checked and confirmed the authenticity of the raw data.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Written informed consent was obtained from the patient for publication of this case report and accompanying images.

Competing interests

The authors declare that they have no competing interests.

Glossary

Abbreviations

Abbreviations:

ACTH

adrenocorticotropic hormone

BP

blood pressure

CT

computerized tomography

FSH

follicle-stimulating hormone

FT3

free triiodothyronine

FT4

free thyroxine

HPV

human papillomavirus

K+

potassium ion

LH

luteinizing hormone

MRI

magnetic resonance imaging

Na+

sodium

PA

pituitary apoplexy

PET-CT

positron emission tomography-computed tomography

POD

postoperative day

TCT

thinprep cytology test

TSH

thyroid stimulating hormone

References

1 

Brougham M, Heusner AP and Adams RD: Acute degenerative changes in adenomas of the pituitary body-with special reference to pituitary apoplexy. J Neurosurg. 7:421–439. 1950. View Article : Google Scholar : PubMed/NCBI

2 

Muthukumar N: Pituitary apoplexy: A comprehensive review. Neurol India. 68:S72–S78. 2020. View Article : Google Scholar : PubMed/NCBI

3 

Bonicki W, Kasperlik-Załuska A, Koszewski W, Zgliczyński W and Wisławski J: Pituitary apoplexy: Endocrine, surgical and oncological emergency. Incidence, clinical course and treatment with reference to 799 cases of pituitary adenomas. Acta Neurochir (Wien). 120:118–122. 1993. View Article : Google Scholar : PubMed/NCBI

4 

Verrees M, Arafah BM and Selman WR: Pituitary tumor apoplexy: Characteristics, treatment, and outcomes. Neurosurg Focus. 16:E62004. View Article : Google Scholar : PubMed/NCBI

5 

Sibal L, Ball SG, Connolly V, James RA, Kane P, Kelly WF, Kendall-Taylor P, Mathias D, Perros P, Quinton R and Vaidya B: Pituitary apoplexy: A review of clinical presentation, management and outcome in 45 cases. Pituitary. 7:157–163. 2004. View Article : Google Scholar : PubMed/NCBI

6 

Lubina A, Olchovsky D, Berezin M, Ram Z, Hadani M and Shimon I: Management of pituitary apoplexy: Clinical experience with 40 patients. Acta Neurochir (Wien). 147:151–157. 2005. View Article : Google Scholar : PubMed/NCBI

7 

Capatina C, Inder W, Karavitaki N and Wass JA: Management of endocrine disease: Pituitary tumour apoplexy. Eur J Endocrinol. 172:R179–R190. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Bills DC, Meyer FB, Laws ER Jr, Davis DH, Ebersold MJ, Scheithauer BW, Ilstrup DM and Abboud CF: A retrospective analysis of pituitary apoplexy. Neurosurgery. 33:602–609. 1993. View Article : Google Scholar : PubMed/NCBI

9 

Bujawansa S, Thondam SK, Steele C, Cuthbertson DJ, Gilkes CE, Noonan C, Bleaney CW, Macfarlane IA, Javadpour M and Daousi C: Presentation, management and outcomes in acute pituitary apoplexy: A large single-centre experience from the United Kingdom. Clin Endocrinol (Oxf). 80:419–424. 2014. View Article : Google Scholar : PubMed/NCBI

10 

Dubuisson AS, Beckers A and Stevenaert A: Classical pituitary tumour apoplexy: Clinical features, management and outcomes in a series of 24 patients. Clin Neurol Neurosurg. 109:63–70. 2007. View Article : Google Scholar : PubMed/NCBI

11 

Nawar RN, AbdelMannan D, Selman WR and Arafah BM: Pituitary tumor apoplexy: A review. J Intensive Care Med. 23:75–90. 2008. View Article : Google Scholar : PubMed/NCBI

12 

Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB and Wass JA: Classical pituitary apoplexy: Clinical features, management and outcome. Clin Endocrinol (Oxf). 51:181–188. 1999. View Article : Google Scholar : PubMed/NCBI

13 

Ranabir S and Baruah MP: Pituitary apoplexy. Indian J Endocrinol Metab. 15 (Suppl 3):S188–S196. 2011. View Article : Google Scholar : PubMed/NCBI

14 

Briet C, Salenave S, Bonneville JF, Laws ER and Chanson P: Pituitary apoplexy. Endocr Rev. 36:622–645. 2015. View Article : Google Scholar : PubMed/NCBI

15 

Pivonello R, De Leo M, Cozzolino A and Colao A: The treatment of cushing's disease. Endocr Rev. 36:385–486. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Mullur R, Liu YY and Brent GA: Thyroid hormone regulation of metabolism. Physiol Rev. 94:355–382. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, Shao L, Tian Y, Dong Y, Zheng C, et al: Status of hypertension in China: Results from the China hypertension survey, 2012–2015. Circulation. 137:2344–2356. 2018. View Article : Google Scholar : PubMed/NCBI

18 

Kelly AM: The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emerg Med J. 18:205–207. 2018. View Article : Google Scholar : PubMed/NCBI

19 

Reith FC, Van den Brande R, Synnot A, Gruen R and Maas AI: The reliability of the Glasgow Coma Scale: A systematic review. Intensive Care Med. 42:3–15. 2016. View Article : Google Scholar : PubMed/NCBI

20 

Noh S and Kim SH, Cho NH and Kim SH: Rapid reticulin fiber staining method is helpful for the diagnosis of pituitary adenoma in frozen section. Endocr Pathol. 26:178–184. 2015. View Article : Google Scholar : PubMed/NCBI

21 

Shaikh AA, Williams DM, Stephens JW, Boregowda K, Udiawar MV and Price DE: Natural history of pituitary apoplexy: A long-term follow-up study. Postgrad Med J. 99:595–598. 2023. View Article : Google Scholar : PubMed/NCBI

22 

Johnston PC, Hamrahian AH, Weil RJ and Kennedy L: Pituitary tumor apoplexy. J Clin Neurosci. 22:939–944. 2015. View Article : Google Scholar : PubMed/NCBI

23 

Fyrmpas G, Constantinidis J, Foroglou N and Selviaridis P: Pituitary apoplexy following endoscopic sinus surgery. J Laryngol Otol. 124:677–679. 2010. View Article : Google Scholar : PubMed/NCBI

24 

Absalom M, Rogers KH, Moulton RJ and Mazer CD: Pituitary apoplexy after coronary artery surgery. Anesth Analg. 76:648–649. 1993. View Article : Google Scholar : PubMed/NCBI

25 

Suri H and Dougherty C: Presentation and management of headache in pituitary apoplexy. Curr Pain Headache Rep. 23:612019. View Article : Google Scholar : PubMed/NCBI

26 

Barkhoudarian G and Kelly DF: Pituitary apoplexy. Neurosurg Clin N Am. 30:457–463. 2019. View Article : Google Scholar : PubMed/NCBI

27 

Hong CS and Omay SB: Pituitary Apoplexy. N Engl J Med. 387:23662022. View Article : Google Scholar : PubMed/NCBI

28 

Goyal P, Utz M, Gupta N, Kumar Y, Mangla M, Gupta S and Mangla R: Clinical and imaging features of pituitary apoplexy and role of imaging in differentiation of clinical mimics. Quant Imaging Med Surg. 8:219–231. 2018. View Article : Google Scholar : PubMed/NCBI

29 

Rajasekaran S, Vanderpump M, Baldeweg S, Drake W, Reddy N, Lanyon M, Markey A, Plant G, Powell M, Sinha S and Wass J: UK guidelines for the management of pituitary apoplexy. Clin Endocrinol (Oxf). 74:9–20. 2011. View Article : Google Scholar : PubMed/NCBI

30 

Feldt-Rasmussen U, Klose M and Benvenga S: Interactions between hypothalamic pituitary thyroid axis and other pituitary dysfunctions. Endocrine. 62:519–527. 2018. View Article : Google Scholar : PubMed/NCBI

31 

Abdulbaki A and Kanaan I: The impact of surgical timing on visual outcome in pituitary apoplexy: Literature review and case illustration. Surg Neurol Int. 8:162017. View Article : Google Scholar : PubMed/NCBI

32 

Ayuk J, McGregor EJ, Mitchell RD and Gittoes NJ: Acute management of pituitary apoplexy-surgery or conservative management? Clin Endocrinol (Oxf). 61:747–752. 2004. View Article : Google Scholar : PubMed/NCBI

33 

Gruber A, Clayton J, Kumar S, Robertson I, Howlett TA and Mansell P: Pituitary apoplexy: Retrospective review of 30 patients-is surgical intervention always necessary? Br J Neurosurg. 20:379–385. 2006. View Article : Google Scholar : PubMed/NCBI

34 

Mura P, Cossu AP, Musu M, De Giudici LM, Corda L, Zucca R and Finco G: Pituitary apoplexy after laparoscopic surgery: A case report. Eur Rev Med Pharmacol Sci. 18:3524–3527. 2014.PubMed/NCBI

35 

McClain IJ and Skidd PM: Case of pituitary apoplexy after surgery. J Neuroophthalmol. 42:e385–e386. 2022. View Article : Google Scholar : PubMed/NCBI

36 

Liberale G, Bruninx G, Vanderkelen B, Dubois E, Vandueren E and Verhelst G: Pituitary apoplexy after aortic abdominal aneurysm surgery: A case report. Acta Chir Belg. 106:77–80. 2006. View Article : Google Scholar : PubMed/NCBI

37 

Naito Y, Mori J, Tazoe J, Tomida A, Yagyu S, Nakajima H, Iehara T, Tatsuzawa K, Mukai T and Hosoi H: Pituitary apoplexy after cardiac surgery in a 14-year-old girl with Carney complex: A case report. Endocr J. 66:1117–1123. 2019. View Article : Google Scholar : PubMed/NCBI

38 

Hidiroglu M, Kucuker A, Ucaroglu E, Kucuker SA and Sener E: Pituitary apoplexy after cardiac surgery. Ann Thorac Surg. 89:1635–1637. 2010. View Article : Google Scholar : PubMed/NCBI

39 

Yakupoglu H, Onal MB, Civelek E, Kircelli A and Celasun B: Pituitary apoplexy after cardiac surgery in a patient with subclinical pituitary adenoma: Case report with review of literature. Neurol Neurochir Pol. 44:520–525. 2010. View Article : Google Scholar : PubMed/NCBI

40 

Yoshino M, Sekine Y, Koh E, Hata A and Hashimoto N: Pituitary apoplexy after surgical treatment of lung cancer. Ann Thorac Surg. 98:1830–1832. 2014. View Article : Google Scholar : PubMed/NCBI

41 

Joo C, Ha G and Jang Y: Pituitary apoplexy following lumbar fusion surgery in prone position: A case report. Medicine (Baltimore). 97:e06762018. View Article : Google Scholar : PubMed/NCBI

42 

Goel V, Debnath UK, Singh J and Brydon HL: Pituitary apoplexy after joint arthroplasty. J Arthroplasty. 24:826.e7–10. 2009. View Article : Google Scholar : PubMed/NCBI

43 

Kim YH, Lee SW, Son DW and Cha SH: Pituitary apoplexy following mitral valvuloplasty. J Korean Neurosurg Soc. 57:289–291. 2015. View Article : Google Scholar : PubMed/NCBI

44 

Mizuno T: Pituitary apoplexy with third cranial nerve palsy after off-pump coronary artery bypass grafting. Interact Cardiovasc Thorac Surg. 13:240–242. 2011. View Article : Google Scholar : PubMed/NCBI

45 

Thurtell MJ, Besser M and Halmagyi GM: Pituitary apoplexy causing isolated blindness after cardiac bypass surgery. Arch Ophthalmol. 126:576–578. 2008. View Article : Google Scholar : PubMed/NCBI

46 

Matsusaki T, Morimatsu H, Matsumi J, Matsuda H, Sato T, Sato K, Mizobuchi S, Yagi T and Morita K: Pituitary apoplexy precipitating diabetes insipidus after living donor liver transplantation. J Anesth. 25:108–111. 2011. View Article : Google Scholar : PubMed/NCBI

47 

Telesca M, Santini F and Mazzucco A: Adenoma related pituitary apoplexy disclosed by ptosis after routine cardiac surgery: Occasional reappearance of a dismal complication. Intensive Care Med. 35:185–186. 2009. View Article : Google Scholar : PubMed/NCBI

48 

Madhusudhan S, Madhusudhan TR, Haslett RS and Sinha A: Pituitary apoplexy following shoulder arthroplasty: A case report. J Med Case Rep. 5:2842011. View Article : Google Scholar : PubMed/NCBI

49 

Cohen A, Kishore K, Wolansky L and Frohman L: Pituitary apoplexy occurring during large volume liposuction surgery. J Neuroophthalmol. 24:31–33. 2004. View Article : Google Scholar : PubMed/NCBI

50 

Shapiro LM: Pituitary apoplexy following coronary artery bypass surgery. J Surg Oncol. 44:66–68. 1990. View Article : Google Scholar : PubMed/NCBI

51 

Tansel T, Ugurlucan M and Onursal E: Pituitary apoplexy following coronary artery bypass grafting: Report of a case. Acta Chir Belg. 110:484–486. 2010. View Article : Google Scholar : PubMed/NCBI

52 

Slavin ML and Budabin M: Pituitary apoplexy associated with cardiac surgery. Am J Ophthalmol. 98:291–296. 1984. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

September-2024
Volume 28 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yu X, Shi C, Jiang L and Liu K: Pituitary apoplexy after surgery for cervical stump adenocarcinoma: A case report and literature review. Oncol Lett 28: 411, 2024.
APA
Yu, X., Shi, C., Jiang, L., & Liu, K. (2024). Pituitary apoplexy after surgery for cervical stump adenocarcinoma: A case report and literature review. Oncology Letters, 28, 411. https://doi.org/10.3892/ol.2024.14543
MLA
Yu, X., Shi, C., Jiang, L., Liu, K."Pituitary apoplexy after surgery for cervical stump adenocarcinoma: A case report and literature review". Oncology Letters 28.3 (2024): 411.
Chicago
Yu, X., Shi, C., Jiang, L., Liu, K."Pituitary apoplexy after surgery for cervical stump adenocarcinoma: A case report and literature review". Oncology Letters 28, no. 3 (2024): 411. https://doi.org/10.3892/ol.2024.14543